ZIMMER BIOMET HOLDINGS, INC. Payments to Acquire Debt Securities, Available-for-sale
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Payments to Acquire Debt Securities, Available-for-sale of $1.50 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2019-02-26
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2016-12-31 was $100.00K, a 99.72% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2016-09-30 was $200.00K, a 99.24% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2016-06-30 was $900.00K.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2016-03-31 was $300.00K, a 99.80% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for fiscal 2016 was $1.50M, a 99.30% decline from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for fiscal 2015 was $214.80M, a 84.10% decline from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for fiscal 2014 was $1.35B, a 84.37% increase from fiscal 2013.
- ZIMMER BIOMET HOLDINGS, INC. payments to acquire debt securities, available-for-sale for fiscal 2013 was $732.70M, a 35.17% decline from fiscal 2012.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2016-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $300.00K derived: sum of 2 quarters · filed 2019-02-26 | $1.20M derived: sum of 3 quarters · filed 2019-02-26 | $1.50M 10-K · filed 2019-02-26 |
| 2016-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $1.10M derived: sum of 2 quarters · filed 2017-11-06 | $1.40M 10-Q · filed 2017-11-06 | $37.20M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.20M 10-Q · filed 2017-08-08 | $37.00M derived: sum of 3 quarters · filed 2018-02-27 | $63.40M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $300.00K 10-Q · filed 2017-05-09 | $36.10M derived: sum of 2 quarters · filed 2018-02-27 | $62.50M derived: sum of 3 quarters · filed 2018-02-27 | $62.50M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $35.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $62.20M derived: sum of 2 quarters · filed 2018-02-27 | $62.20M derived: sum of 3 quarters · filed 2018-02-27 | $214.80M 10-K · filed 2018-02-27 |
| 2015-09-30 | $26.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $26.40M derived: sum of 2 quarters · filed 2016-11-08 | $179.00M 10-Q · filed 2016-11-08 | $379.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $152.60M 10-Q · filed 2016-08-08 | $353.40M derived: sum of 3 quarters · filed 2017-03-01 | $720.20M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $152.60M 10-Q · filed 2016-05-10 | $353.40M derived: sum of 2 quarters · filed 2017-03-01 | $720.20M derived: sum of 3 quarters · filed 2017-03-01 | $902.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $200.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $567.60M derived: sum of 2 quarters · filed 2017-03-01 | $750.20M derived: sum of 3 quarters · filed 2017-03-01 | $1.35B 10-K · filed 2017-03-01 |
| 2014-09-30 | $366.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $549.40M derived: sum of 2 quarters · filed 2015-11-09 | $1.15B 10-Q · filed 2015-11-09 | $1.30B derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $182.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $783.30M 10-Q · filed 2015-08-10 | $935.70M derived: sum of 3 quarters · filed 2016-02-29 | $1.15B derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $600.70M 10-Q · filed 2015-05-07 | $753.10M derived: sum of 2 quarters · filed 2016-02-29 | $967.40M derived: sum of 3 quarters · filed 2016-02-29 | $1.24B derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $152.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $366.70M derived: sum of 2 quarters · filed 2016-02-29 | $637.90M derived: sum of 3 quarters · filed 2016-02-29 | $732.70M 10-K · filed 2016-02-29 |
| 2013-09-30 | $214.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $485.50M derived: sum of 2 quarters · filed 2014-11-05 | $580.30M 10-Q · filed 2014-11-05 | $908.70M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $271.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $366.00M 10-Q · filed 2014-08-07 | $694.40M derived: sum of 3 quarters · filed 2015-02-23 | $958.60M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $94.80M 10-Q · filed 2014-05-06 | $423.20M derived: sum of 2 quarters · filed 2015-02-23 | $687.40M derived: sum of 3 quarters · filed 2015-02-23 | $969.30M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $328.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $592.60M derived: sum of 2 quarters · filed 2015-02-23 | $874.50M derived: sum of 3 quarters · filed 2015-02-23 | $1.13B 10-K · filed 2015-02-23 |
| 2012-09-30 | $264.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $546.10M derived: sum of 2 quarters · filed 2013-11-12 | $801.70M 10-Q · filed 2013-11-12 | $1.06B derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $281.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $537.50M 10-Q · filed 2013-08-07 | $795.80M derived: sum of 3 quarters · filed 2014-02-28 | $1.01B derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $255.60M 10-Q · filed 2013-05-08 | $513.90M derived: sum of 2 quarters · filed 2014-02-28 | $731.00M derived: sum of 3 quarters · filed 2014-02-28 | $852.40M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $258.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $475.40M derived: sum of 2 quarters · filed 2014-02-28 | $596.80M derived: sum of 3 quarters · filed 2014-02-28 | $662.10M 10-K · filed 2014-02-28 |
| 2011-09-30 | $217.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $338.50M derived: sum of 2 quarters · filed 2012-11-06 | $403.80M 10-Q · filed 2012-11-06 | $716.50M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $121.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $186.70M 10-Q · filed 2012-08-07 | $499.40M derived: sum of 3 quarters · filed 2013-02-27 | $596.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $65.30M 10-Q · filed 2012-05-03 | $378.00M derived: sum of 2 quarters · filed 2013-02-27 | $474.60M derived: sum of 3 quarters · filed 2013-02-27 | $474.60M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $312.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $409.30M derived: sum of 2 quarters · filed 2013-02-27 | $409.30M derived: sum of 3 quarters · filed 2013-02-27 | $413.30M 10-K · filed 2013-02-27 |
| 2010-09-30 | $96.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $96.60M derived: sum of 2 quarters · filed 2011-11-02 | $100.60M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $4.00M 10-Q · filed 2011-08-08 | ||
| 2010-03-31 | $4.00M 10-Q · filed 2011-05-05 | |||
| 2009-12-31 | $66.40M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |